Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Symposium
Updated data from Phase I/II dose-escalation study of RVU120 show four disease stabilizations in advanced solid…
Rhino Propels Federated AI into the Enterprise Tech Stack